vs

Side-by-side financial comparison of NATURAL GAS SERVICES GROUP INC (NGS) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $46.1M, roughly 1.6× NATURAL GAS SERVICES GROUP INC). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 13.5%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-20.7M).

Southern Company Gas, formerly AGL Resources, is an American Fortune 500 energy services holding company headquartered in Atlanta, Georgia. The company's operations consist of natural gas distribution, wholesale services, retail operations, and midstream operations. Southern Company Gas is one of the largest natural gas distribution companies in the United States. The company serves approximately 4.5 million utility customers through its regulated distribution subsidiaries across four states....

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

NGS vs PBYI — Head-to-Head

Bigger by revenue
PBYI
PBYI
1.6× larger
PBYI
$75.5M
$46.1M
NGS
Growing faster (revenue YoY)
PBYI
PBYI
+14.2% gap
PBYI
27.7%
13.5%
NGS
More free cash flow
PBYI
PBYI
$35.1M more FCF
PBYI
$14.4M
$-20.7M
NGS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NGS
NGS
PBYI
PBYI
Revenue
$46.1M
$75.5M
Net Profit
$4.1M
Gross Margin
69.3%
Operating Margin
15.4%
22.7%
Net Margin
8.9%
Revenue YoY
13.5%
27.7%
Net Profit YoY
43.2%
EPS (diluted)
$0.32
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NGS
NGS
PBYI
PBYI
Q4 25
$46.1M
$75.5M
Q3 25
$43.4M
$54.5M
Q2 25
$41.4M
$52.4M
Q1 25
$41.4M
$46.0M
Q4 24
$40.7M
$59.1M
Q3 24
$80.5M
Q2 24
$47.1M
Q1 24
$43.8M
Net Profit
NGS
NGS
PBYI
PBYI
Q4 25
$4.1M
Q3 25
$5.8M
$8.8M
Q2 25
$5.2M
$5.9M
Q1 25
$4.9M
$3.0M
Q4 24
$2.9M
Q3 24
$20.3M
Q2 24
$-4.5M
Q1 24
$-4.8M
Gross Margin
NGS
NGS
PBYI
PBYI
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
NGS
NGS
PBYI
PBYI
Q4 25
15.4%
22.7%
Q3 25
24.8%
17.6%
Q2 25
24.0%
12.7%
Q1 25
23.0%
8.7%
Q4 24
14.9%
22.6%
Q3 24
27.4%
Q2 24
-4.6%
Q1 24
-5.3%
Net Margin
NGS
NGS
PBYI
PBYI
Q4 25
8.9%
Q3 25
13.3%
16.2%
Q2 25
12.5%
11.2%
Q1 25
11.7%
6.5%
Q4 24
7.0%
Q3 24
25.2%
Q2 24
-9.6%
Q1 24
-11.0%
EPS (diluted)
NGS
NGS
PBYI
PBYI
Q4 25
$0.32
$0.26
Q3 25
$0.46
$0.17
Q2 25
$0.41
$0.12
Q1 25
$0.38
$0.06
Q4 24
$0.22
$0.40
Q3 24
$0.41
Q2 24
$-0.09
Q1 24
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NGS
NGS
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$97.5M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$274.7M
$130.3M
Total Assets
$586.8M
$216.3M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NGS
NGS
PBYI
PBYI
Q4 25
$97.5M
Q3 25
$94.4M
Q2 25
$325.0K
$96.0M
Q1 25
$2.1M
$93.2M
Q4 24
$2.1M
$101.0M
Q3 24
$96.7M
Q2 24
$96.8M
Q1 24
$107.2M
Total Debt
NGS
NGS
PBYI
PBYI
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
NGS
NGS
PBYI
PBYI
Q4 25
$274.7M
$130.3M
Q3 25
$271.4M
$115.3M
Q2 25
$266.2M
$104.7M
Q1 25
$260.3M
$97.1M
Q4 24
$255.1M
$92.1M
Q3 24
$71.1M
Q2 24
$48.5M
Q1 24
$51.0M
Total Assets
NGS
NGS
PBYI
PBYI
Q4 25
$586.8M
$216.3M
Q3 25
$562.3M
$202.9M
Q2 25
$525.5M
$194.9M
Q1 25
$501.7M
$196.2M
Q4 24
$492.5M
$213.3M
Q3 24
$220.7M
Q2 24
$205.0M
Q1 24
$214.1M
Debt / Equity
NGS
NGS
PBYI
PBYI
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NGS
NGS
PBYI
PBYI
Operating Cash FlowLast quarter
$13.9M
$14.4M
Free Cash FlowOCF − Capex
$-20.7M
$14.4M
FCF MarginFCF / Revenue
-44.8%
19.1%
Capex IntensityCapex / Revenue
74.9%
0.0%
Cash ConversionOCF / Net Profit
3.38×
TTM Free Cash FlowTrailing 4 quarters
$-58.6M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NGS
NGS
PBYI
PBYI
Q4 25
$13.9M
$14.4M
Q3 25
$16.8M
$9.7M
Q2 25
$11.0M
$14.1M
Q1 25
$21.3M
$3.6M
Q4 24
$9.4M
$15.6M
Q3 24
$11.0M
Q2 24
$1.0M
Q1 24
$11.2M
Free Cash Flow
NGS
NGS
PBYI
PBYI
Q4 25
$-20.7M
$14.4M
Q3 25
$-25.1M
$9.7M
Q2 25
$-14.8M
$14.1M
Q1 25
$2.0M
$3.6M
Q4 24
$-5.1M
$15.6M
Q3 24
$11.0M
Q2 24
$1.0M
Q1 24
FCF Margin
NGS
NGS
PBYI
PBYI
Q4 25
-44.8%
19.1%
Q3 25
-57.7%
17.7%
Q2 25
-35.8%
26.8%
Q1 25
4.9%
7.7%
Q4 24
-12.6%
26.4%
Q3 24
13.7%
Q2 24
2.1%
Q1 24
Capex Intensity
NGS
NGS
PBYI
PBYI
Q4 25
74.9%
0.0%
Q3 25
96.5%
0.0%
Q2 25
62.4%
0.0%
Q1 25
46.5%
0.1%
Q4 24
35.8%
0.0%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.0%
Cash Conversion
NGS
NGS
PBYI
PBYI
Q4 25
3.38×
Q3 25
2.90×
1.10×
Q2 25
2.12×
2.41×
Q1 25
4.38×
1.21×
Q4 24
3.29×
Q3 24
0.54×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons